Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study

Jeewoo Kang; Ji Won Lee; Ohsang Kwon

doi:10.1016/j.jaad.2022.12.005

Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study

J Am Acad Dermatol. 2023 May;88(5):1170-1173. doi: 10.1016/j.jaad.2022.12.005. Epub 2022 Dec 13.

Authors

Jeewoo Kang¹, Ji Won Lee¹, Ohsang Kwon²

Affiliations

¹ Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea.
² Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Cutaneous Aging and Hair Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Republic of Korea. Electronic address: oskwon@snu.ac.kr.

PMID: 36526083
DOI: 10.1016/j.jaad.2022.12.005

No abstract available

Keywords: EIA; LDOM; alopecia; anticancer; anticancer therapy-induced alopecia; antineoplastic; breast cancer; chemotherapy; endocrine therapy; endocrine therapy-induced alopecia; low-dose oral minoxidil; pCIA; persistent chemotherapy-induced alopecia; topical minoxidil.

MeSH terms

Administration, Topical
Alopecia / chemically induced
Alopecia / drug therapy
Breast Neoplasms* / drug therapy
Female
Humans
Minoxidil*
Patients
Retrospective Studies
Treatment Outcome

Substances

Minoxidil